Condition: Diffuse Large B-cell Lymphoma · Sponsor: The University of Texas Health Science Center at San Antonio
This study is developed by the investigator and is a, phase I, single arm, clinical trial that will enroll subjects with untreated diffuse large B-cell lymphoma (DLCBL) at high risk for poor outcome. The types of treatments given will be shared with participants. The aims are: 1. To assess the safety and how well the participants tolerate the treatment 2. Assess the response of the tumor to treatment to estimate complete response 3. Assess the response of the tumor to treatment to estimate progression-free survival
This description comes directly from the study's public registry record.
Adolfo Diaz Duque, MD · 210-450-5904 · diazduque@uthscsa.edu
Ricardo E Aguiar, MD · 210-567-4860 · aguiarr@uthscsa.edu
Always discuss trial participation with your own doctor first.
| University Hospital System | San Antonio, Texas, United States | Recruiting |
| University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06977711